Reduced-dose versus high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: predefined 2-year follow-up study
Year: 2023
Type: article
Source: Annals of the Rheumatic Diseases
Authors: Shunsuke Furuta, Daiki Nakagomi, Yoshihisa Kobayashi, Masaki Hiraguri, Takao Sugiyama, Koichi Amano, Takeshi Umibe, Hajime Kono, Kazuhiro Kurasawa, Yasuhiko Kita, Ryutaro Matsumura, Yuko Kaneko, Keita Ninagawa, Keiju Hiromura, Shin-ichiro Kagami, Yosuke Inaba, Hideki Hanaoka, Kei Ikeda, Hiroshi Nakajima
Institutions: Chiba University, Chiba University Hospital, University of Yamanashi Hospital, University of Yamanashi, Chiba Aoba Municipal Hospital, Japanese Red Cross Narita Hospital, National Hospital Organization, National Hospital Organization Shimoshizu Hospital, Saitama Medical Center, Saitama Medical University, Saitama Medical University, Matsudo City Hospital, Teikyo University, Dokkyo Medical University, Yokohama Rosai Hospital, Chiba East Hospital, Keio University, Hokkaido University, Gunma University, Asahi General Hospital, Synergy Institute for Futuristic Mucosal Vaccine Research and Development, Chiba University
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: Chiba University
OpenAlex ID: W4386923262